1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
(
- Contribution to journal › Article
- 2022
-
Mark
Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure
(
- Contribution to journal › Article
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
(
- Contribution to journal › Article
- 2019
-
Mark
Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors : Results from the prospective TEDDY study
(
- Contribution to journal › Article
-
Mark
Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants : An ENIGMA report
(
- Contribution to journal › Article
- 2018
-
Mark
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
(
- Contribution to journal › Article
-
Mark
CM-Score : A validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe
(
- Contribution to journal › Article
- 2017
-
Mark
Common cancers share familial susceptibility : Implications for cancer genetics and counselling
(
- Contribution to journal › Article
-
Mark
Regulating the advertising of genetic tests in Europe : a balancing act
(
- Contribution to journal › Article
- 2014
-
Mark
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
(
- Contribution to journal › Article